menu
    • menu
    [{"orgOrder":0,"company":"EPAX NORWAY AS","sponsor":"M\u00f8reforsking AS","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"NORWAY","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Ceto 10","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"EPAX NORWAY AS","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"EPAX NORWAY AS \/ M\u00f8reforsking AS","highestDevelopmentStatusID":"1","companyTruncated":"EPAX NORWAY AS \/ M\u00f8reforsking AS"},{"orgOrder":0,"company":"EPAX NORWAY AS","sponsor":"M\u00f8reforsking AS","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"NORWAY","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Ceto 10","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"EPAX NORWAY AS","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"EPAX NORWAY AS \/ M\u00f8reforsking AS","highestDevelopmentStatusID":"1","companyTruncated":"EPAX NORWAY AS \/ M\u00f8reforsking AS"},{"orgOrder":0,"company":"EPAX NORWAY AS","sponsor":"Cutest Systems Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"NORWAY","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Omega-3-9-11","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"EPAX NORWAY AS","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"EPAX NORWAY AS \/ Cutest Systems Ltd","highestDevelopmentStatusID":"1","companyTruncated":"EPAX NORWAY AS \/ Cutest Systems Ltd"},{"orgOrder":0,"company":"EPAX NORWAY AS","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"NORWAY","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Polyunsaturated Fatty Acid","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"EPAX NORWAY AS","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"EPAX NORWAY AS \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"EPAX NORWAY AS \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by EPAX NORWAY AS

    Menu

    EPAX NORWAY AS

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Omega-3-9-11

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Cutest Systems Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function

                            Details : Omega-3-9-11 is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            August 21, 2025

                            Lead Product(s) : Omega-3-9-11

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Cutest Systems Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Polyunsaturated Fatty Acid

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality

                            Details : Polyunsaturated Fatty Acid is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Infertility, Male.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            April 30, 2025

                            Lead Product(s) : Polyunsaturated Fatty Acid

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ceto 10

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Møreforsking AS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Nutritional Study of Fish Oil in Skin Quality in Healthy Women

                            Details : Ceto 10 is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            November 19, 2021

                            Lead Product(s) : Ceto 10

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Møreforsking AS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            EPAX NORWAY AS

                            Norway arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ceto 10

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Møreforsking AS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)

                            Details : Ceto 10 is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            February 24, 2021

                            Lead Product(s) : Ceto 10

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Møreforsking AS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth